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Abstract
The progressive solving of the conformation of aggregated proteins and the conceptual
understanding of the biology of inclusion bodies in recombinant bacteria is providing exciting
insights on protein folding and quality. Interestingly, newest data also show an unexpected
functional and structural complexity of soluble recombinant protein species and picture the whole
bacterial cell factory scenario as more intricate than formerly believed.
Commentary
The conformational quality of soluble recombinant pro-
teins is an emerging matter of concern, especially when
the obtained products are to be used for functional or
interactomic analyses [1]. In the context of recombinant
protein production, the general believing that soluble
protein species are properly folded and fully functional in
contrast to the misfolded and inactive protein versions
trapped in insoluble inclusion bodies [2], cannot be
longer supported by current research data. The dropping
of independent references to inclusion bodies as entities
formed by functional protein species with native second-
ary structure is progressively increasing, and the structural
and functional diversity of the model proteins used in
these studies [3-13] does leave little room to speculate
about this fact as being an artefact or a peculiarity of a lim-
ited number of protein species. Recent reviews in this area
have presented properly folded proteins as natural com-
ponents of inclusion bodies [10,14], indirectly compro-
mising the paradigm of recombinant protein solubility as
equivalent to protein conformational quality [15].
Indeed, the occurrence of functional proteins as impor-
tant components of bacterial aggregates prompts to recon-
sider the conformational quality of protein species
occurring in the soluble cell fraction of inclusion body-
forming cells, that might be lower than expected. Several
indirect observations are also in this line; (i) the func-
tional quality of recombinant proteins in E. coli is affected
in parallel by physical parameters such as temperature
(high temperature impairs protein activity in both soluble
and insoluble cell fractions) [16] and physiological condi-
tions such as the availability of chaperones (a molar
excess of DnaKJ inactivates both soluble and insoluble
recombinant proteins) [17]; (ii) in vivo disintegration of
inclusion bodies is strongly dependent on proteolytic deg-
radation [18-21] for which DnaK is required [20], indicat-
ing a tight surveillance of the quality control system over
aggregated protein species; (iii) inclusion body-forming
proteins can complete their folding process once embed-
ded in these aggregates [22]; (iv) the soluble versions of
recombinant proteins can occur as soluble aggregates
[23,24]; (v) the functional quality (measured for a model
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specific emission) of soluble protein versions can be
lower than that of the inclusion body counterparts [3],
and be eventually improved by reducing the growth tem-
perature of recombinant cells from 37 to 16°C [16]. This
indicates that at 37°C, an important fraction of soluble
protein species are inactive, suggesting that they have not
reached their native conformation. This has been very
recently explored by sub-fractioning the soluble popula-
tion of an inclusion body-forming recombinant GFP and
their subsequent functional analysis. Indeed, there is a
large functional diversity within the soluble protein pop-
ulation (accompanied by an extremely high abundance of
soluble aggregates, either globular or fibrilar) [24], that
prompts to observe the specific fluorescence of the soluble
protein version as an average rather than a canonical value
defined by a single type of molecular species.
In this scenario, recombinant proteins in producing cells
can be seen as adopting "a continuum of forms" [23]
expanding from soluble to insoluble cell fractions, and
inclusion bodies as insoluble "clusters" of protein species
[19]. Therefore, soluble versions of a given protein would
not necessarily show better conformational quality than
the aggregated counterparts, although the average biolog-
ical activity (specific activity for enzymes or specific fluo-
rescence for fluorescent proteins) is in general higher in
the soluble cell fraction [3,24]. Interestingly, the specific
enzymatic activities (or fluorescence emission) of soluble
and insoluble protein versions tend to adopt similar val-
ues under specific conditions such as in DnaK knockout
mutants [25,26]. Therefore, the soluble and insoluble
"virtual" cell fractions in bacteria [14] are now regarded as
more virtual than ever, as the main feature distinguishing
soluble and inclusion body protein species might be the
dispersed-clustered status rather than the biological activ-
ity.
From a practical point of view, these emerging concepts
about protein aggregation in recombinant bacteria have
remarkable implications. First, inclusion bodies formed
by enzymes can be straightforward used as catalysers in
industry-relevant enzymatic reactions skipping any previ-
ous in vitro refolding protocols [5-7]. Second, the quality
of inclusion body proteins can be dramatically enhanced
by producing them at suboptimal temperatures. This
should not only permit the production of inclusion bod-
ies with improved catalyzing properties but it also might
favour the controlled in vitro release of functional proteins
from these aggregates. In this regard, the recovery of func-
tional proteins from inclusion bodies has been a largely
used strategy when a desired protein species showed a
high aggregation tendency. Such an approach implies sep-
aration of inclusion bodies, efficient protein unfolding
under extreme denaturation conditions and further
refolding through complex (and often unsuccessful) step
strategies to be optimized for any particular protein spe-
cies [27]. However, in the last years, an increasing piece of
evidence points out that inclusion bodies with high con-
tent of native-like structure could be easily solubilised in
non-denaturing conditions avoiding strong denaturation
and refolding steps. A set of non related proteins, namely
GFP [28], archaeon proteins, cytokines, immunoglobu-
lin-folded proteins [29] and β-2-microglobulin [30], have
been successfully extracted from inclusion bodies without
the need of denaturing conditions, basically using as sol-
ubilising agents L-arginine and GdnHCl at non-denatur-
ing concentrations [28,29]. Also in this line, Menart and
co-workers observed that functional proteins could be
easily extracted from inclusion bodies using non denatur-
ing mild detergents and polar solvents, provided that the
cells would have been cultured under suboptimal temper-
atures [12]. Such inclusion bodies, being a straightfor-
ward source of soluble proteins, were named "non-
classical" because of their unexpected high content of
functional, extractable species. Although sufficient data
has been now accumulated to infer that in general, inclu-
sion bodies are non-classical by nature (regarding the
unlink between solubility and activity) [15], this interest-
ing approach would potentially permit to skip complex
refolding procedures by engineering the quality of inclu-
sion body proteins during the production process. In very
recent papers, Peternel and co-workers reported not only
the successful extraction of functional polypeptides from
inclusion bodies but also the fact that, in some cases, the
biological activity of these inclusion body-solubilised
proteins was comparable or even higher that than found
in the soluble fraction. For instance, human granulocyte-
stimulating factor (hG-CSF), GFP and lymphotoxin α (LT-
α) extracted from inclusion bodies represented around
the 98%, 40% and 25%, respectively, of the total biologi-
cal activity and fluorescence emission in the recombinant
protein producing-cells [31,32]. Again, the different struc-
tural and biological properties of the proteins for which
this principle has been proved indicate that the extracta-
bility of functional proteins from inclusion bodies is not
a particular issue, although its applicability at large scale
needs to be further evaluated. On the other side, as an
additional strategy, the specific activity of inclusion body
proteins can be successfully enhanced by down-regulating
the levels of recombinant gene expression [33,34].
Finally, since early recombinant DNA times, when the for-
mation of inclusion bodies was noticed as a general unde-
sirable event [35], enhancing protein solubility has been
compulsory pursued through diverse approaches. The
need for soluble proteins for many research, industrial
and pharmaceutical applications has pushed microbiol-
ogists, biochemists and chemical engineers to modify cell,
protein and process conditions (using protease-deficientPage 2 of 5
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regions, fusion of solubility tags, minimizing the growth
rate or using weak gene expression induction conditions
among others), in an attempt to favour the occurrence of
the target protein in the soluble cell fraction [36-41].
However, solubility is often observed as an academic
parameter, namely the quotient (in %) between soluble
and total protein and therefore with a questionable prac-
tical value. Interestingly, it is very rare to find in the liter-
ature measures of solubility simultaneous to
determinations of protein yield or functional quality,
when attempting a novel strategy to minimize inclusion
body formation, such as for instance, the co-production of
chaperones along with the recombinant protein species.
In this regard, enhancing the levels of trigger factor and
GroELS increases the solubility of a recombinant lys-
ozyme that shows a specific activity lower than in absence
of additional chaperones [42]. Other chaperone sets have
been observed to promote solubility of target proteins
[40,43,44] without a detailed analysis of protein quality
and activity or by determining specific activity referring it
to cell extracts or total (recombinant or not) protein
[45,46]. Also, there are clear indications that the solubility
enhancement under such conditions might eventually be
associated to an increase of soluble aggregates [47]. Inter-
estingly, lower protein yields obtained during chaperone
co-production result in higher enzymatic activity in cell
extracts and enhanced solubility, as observed by cyclodex-
trin glycosyltransferase [48] and mouse endostatin and
human lysozyme respectively [42].
Furthermore, fine analyses of solubility in combination
with other more useful parameters such as yield of soluble
polypeptide or the biological activity reveal intriguing
physiological events. For instance, co-production of the
DnaKJ chaperone pair along with a target recombinant
protein indeed favours solubility but at expenses of pro-
tein quality and yield [20]. In fact, enhancing the intracel-
lular levels of DnaK, alone or within distinct chaperone
sets (a common strategy to increase solubility) [40], dra-
matically diminishes protein stability through the stimu-
lation of Lon- and ClpP-dependent proteolysis of
inclusion body polypeptides [20]. In this regard, both
yield and quality of a model recombinant GFP and other
unrelated proteins are largely enhanced in DnaK- mutants
[20,25,26], in which the solubility percent value is, as
expected, lower than in wilt type hosts. More intriguingly,
plotting solubility percent data versus protein yield of
functional quality renders extremely good but negative
correlations, under different genetic backgrounds [20] or
production conditions [49]. Preliminary data about non
bacterial protein production systems from our group
obtained by M. Martínez Alonso (not shown) indicate
that such a negative correlation between yield (or quality)
and solubility could be a general issue. Therefore, when
designing a protein production process the most pertinent
strategy should be chosen depending on what parameter
(yield, quality or solubility) is the most relevant to the
final use of the protein. Eventually, recombinant protein
solubility could be merely dependent on the intracellular
concentration of the recombinant protein itself, what
would ultimately fit with the enhanced solubility
observed at low growth rates, low temperatures and weak
doses of gene expression inductor [36,41].
There are still exciting issues regarding bacterial inclusion
bodies that deserve full scientific attention, such as the
solving of the inner molecular organization that allows
the occurrence of proper folded species within a general
amyloid-like aggregate pattern [50,51]. Also, the
sequence-dependent nature of protein aggregation [52-
54] is still poorly known from a mechanistic point of
view. From the biotechnological side, it is widely accepted
that production of aggregation-prone protein triggers cell
responses to conformational stress [55-58], irrespective of
the host used as cell factory [59]. If such set of physiolog-
ical responses cannot be efficiently controlled, enhancing
protein solubility without renouncing to protein quality
might be then a mirage. Surfing the complex network of
cell activities that regulate protein aggregation (for
instance, through rational metabolic engineering) could
be a choice strategy to approach the production of soluble
and high quality recombinant proteins. For such a more
gentle use of cell factories, a deeper comprehension of the
recombinant cell physiology and quality control system is
urgently needed.
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